The groundbreaking approach of the medication represents a significant development in the care of type 2 diabetes. Unlike existing drugs, tirzepatide impacts multiple pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide991268.get-blogging.com/42511872/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment